المؤلفون: G. Stuart Cockerill (2497144), Richard M. Angell (3024213), Alexandre Bedernjak (10319431), Irina Chuckowree (1999153), Ian Fraser (4708297), Jose Gascon-Simorte (10319434), Morgan S. A. Gilman (10319437), James A. D. Good (10319440), Rachel Harland (10319443), Sara M. Johnson (10319446), John H Ludes-Meyers (10319449), Edward Littler (3017169), James Lumley (10319452), Graham Lunn (1622209), Neil Mathews (2644807), Jason S. McLellan (8816639), Michael Paradowski (2209231), Mark E. Peeples (7832042), Claire Scott (2472082), Dereck Tait (10319455), Geraldine Taylor (580506), Michelle Thom (580502), Elaine Thomas (16268), Carol Villalonga Barber (10319458), Simon E. Ward (2237998), Daniel Watterson (543088), Gareth Williams (5148), Paul Young (197463), Kenneth Powell (5022677)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Pharmacology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Chemical Sciences not elsewhere classified, optimization phase, B laboratory strains, IC 50, lung tissue, Oral bioavailability, syncytial virus, optimization process, exercise, RSV infection, 1.2 nM, bioavailable inhibitor, contract organizations, RV 521, Respiratory Syncytial Virus Fusion .

Relation: https://figshare.com/articles/journal_contribution/Discovery_of_Sisunatovir_RV521_an_Inhibitor_of_Respiratory_Syncytial_Virus_Fusion/14233189

الاتاحة: https://doi.org/10.1021/acs.jmedchem.0c01882.s002

المؤلفون: G. Stuart Cockerill (2497144), Richard M. Angell (3024213), Alexandre Bedernjak (10319431), Irina Chuckowree (1999153), Ian Fraser (4708297), Jose Gascon-Simorte (10319434), Morgan S. A. Gilman (10319437), James A. D. Good (10319440), Rachel Harland (10319443), Sara M. Johnson (10319446), John H Ludes-Meyers (10319449), Edward Littler (3017169), James Lumley (10319452), Graham Lunn (1622209), Neil Mathews (2644807), Jason S. McLellan (8816639), Michael Paradowski (2209231), Mark E. Peeples (7832042), Claire Scott (2472082), Dereck Tait (10319455), Geraldine Taylor (580506), Michelle Thom (580502), Elaine Thomas (16268), Carol Villalonga Barber (10319458), Simon E. Ward (2237998), Daniel Watterson (543088), Gareth Williams (5148), Paul Young (197463), Kenneth Powell (5022677)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Pharmacology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Chemical Sciences not elsewhere classified, optimization phase, B laboratory strains, IC 50, lung tissue, Oral bioavailability, syncytial virus, optimization process, exercise, RSV infection, 1.2 nM, bioavailable inhibitor, contract organizations, RV 521, Respiratory Syncytial Virus Fusion .

Relation: https://figshare.com/articles/dataset/Discovery_of_Sisunatovir_RV521_an_Inhibitor_of_Respiratory_Syncytial_Virus_Fusion/14233186

الاتاحة: https://doi.org/10.1021/acs.jmedchem.0c01882.s001